Navigation Links
RX HERCULINK® PLUS Biliary Stent System

ProductsRX HERCULINK® PLUS Biliary Stent System
Company Guidant Corporation
Item RX HERCULINK® PLUS Biliary Stent System
Features 
  • A robust stent design with 9 crests per ring and multiple rings per stent engineered to increase the stent's coverage and radial strength without compromising flexibility
  • XCELON® nylon balloon material offering high-pressure inflation capability and 14 atm RBP
  • A simple to use Rapid Exchange (RX) platform designed for use with a small .014" guide wire and a single physician operator
  • Small 6F guide compatibility for 4.0 to 6.0mm and 7F guide compatibility for 6.5 to 7.0mm
  • Designed for use with a small .014" guide wire to enhance profile, deliverability and crossing
  • Simple to use Rapid Exchange (RX) technology for fast catheter exchanges and single operator control
  • Nine crest, corrugated ring design for coverage and strength
  • Multiple-Links connecting rings for stent flexibility
  • 14 atm RBP delivers high-pressure capabilities in a low-profile system
  • Multi-compliant XCELON® Balloon Material provides sizing flexibility
  • GRIP™ Technology provides excellent security
  • 6F guide for 4.0 - 6.0mm and 7F guide for 6.5 to 7.0mm
  • 5F sheath for 4.0 to 6.0mm and 6F sheath for 6.5 to 7.0mm
Description The RX HERCULINK® PLUS Biliary Stent System is Guidant's high performance .014" guide wire compatible system. It is available in stent diameters of 4.0-6.5mm for the 12mm stent length and 4.0-7.0 mm for the 15mm and 18mm stent lengths.
Info Guidant Corporation
Customer Service: (317) 971-2000
Web site: http://www.guidant.com/

Related medicine products :

1. Express Biliary SD Stent System 150 cm
2. Express Biliary SD Stent System 90 cm
3. Sentinol™ Self-Expanding Nitinol Biliary Stent System
4. Spencer Modified Biliary Wire Guides
5. Zilver 518 Biliary Stent
6. ABSOLUTE™ 0.035 Biliary Self-Expanding Stent System
7. OMNILINK® 0.035 Biliary Stent System
8. DYNALINK® 0.018 Biliary Self-Expanding Stent System
9. WaveMax Biliary Stent
10. Cypher Stent
11. Cypher Sirolimus-eluting Coronary Stent
Introducing the new Platinum 10 concentrator. The Platinum 10 delivers the reliability, performance and value advantage you have come to expect from the Platinum line of concentrators and provides an
...ep's new high pressure/high flow oxygen concentrat...ry applications. This concentrator can replace the...sity can save on equipment needs and overall power...(138 kPa), with up to 8 lpm single or combined dua...
OCD-3000 pnuematic conserving regulator for large cylinder.
...conserver, it's important to have a choice that fi...ynonymous with innovative excellence, offers two g...Liberty™, two totally automatic and value pa...e Mini Liberty can be used 8 hours a day for 3 to ...
Medicine Products:
(Date:12/2/2008)...reast-Specific Gamma Imaging (BSGI) has,been prov...the diagnosis of,invasive lobular carcinoma (ILC)...a molecular breast imaging technique that can see ...r very early stage cancers. When compared to,mamm... (MRI), BSGI has the,greatest sensitivity for det...
(Date:12/2/2008)...FirstCall/ -- UnitedHealth Group,(NYSE: UNH ) i...become "health,care heroes" by learning about chi...and implementing the programs in their communities...ng, health literacy initiative,designed to encour...uth,leaders, to create and implement local hands-...
(Date:12/2/2008)...r areas, experts say , , TUESDAY, Dec. 2..., created to prevent cardiac arrest and deaths in ...w study finds. , "Many hospitals have implement...searcher Dr. Paul S. Chan, a cardiologist at the M...rlier studies had shown that rapid response teams ...
(Date:12/2/2008)...lth Story Project was announced today as the new b...;Clinical Document Architecture for Common Documen... the label for the technical standards developed b...(HL7) for ballot. The new name , ...08 -- "Our group has been working with many ...
Breaking Medicine News(10 mins):Health News:Molecular Breast Imaging Has Greater Sensitivity Over Mammography, Ultrasound and MRI for Invasive Lobular Carcinoma 2Health News:UnitedHealth Group Grants to Help Students and Educators Combat Childhood Obesity 2Health News:Rapid Response Teams Don't Cut Hospital Heart Attacks, Death Rates 2Health News:Rapid Response Teams Don't Cut Hospital Heart Attacks, Death Rates 3Health News: "The Health Story Project" Adopted as New Brand by CDA4CDT : New Brand Underscores Comprehensive Electronic Health Records 2Health News: "The Health Story Project" Adopted as New Brand by CDA4CDT : New Brand Underscores Comprehensive Electronic Health Records 3Health News: "The Health Story Project" Adopted as New Brand by CDA4CDT : New Brand Underscores Comprehensive Electronic Health Records 4Health News: "The Health Story Project" Adopted as New Brand by CDA4CDT : New Brand Underscores Comprehensive Electronic Health Records 5
...e perturbed because of the government’s move to bu...s.//The government, intends to acquire more agricu...up families more veggies to balance their nutritio...griculture has decided to add vegetables, fruits a...
... in Australia have been told that patients undergo...using a mobile phone.// The system includes the pa...their severity, and advice would be organized by...t to medical staff, or an ambulance may be arrange...
...ith prostate cancer were more likely to report a f... among siblings than men who did not have prostate...ity of Michigan Comprehensive Cancer Center. The d...th Study, a population-based study of African-Amer...
...den palpitations while sightseeing around the Taj ...stationed //in the complex of the 17th century mon... has agreed to a request by the Uttar Pradesh Tour...vide space for a medical centre in the Taj complex...
Other Medicine News:Health News:African-Americans With Prostate Cancer More Likely to Have Family History 2
(Date:12/2/2008)...tCall/ -- Micromet, Inc. (Nasdaq: MITI ), a biop...y antibodies for the treatment of cancer, inflamma... it has entered into an agreement expanding its Co...sbridge Capital Limited, a private investment grou...has committed to provide up to $75 million of capi...
(Date:12/1/2008)...eGen has announced that an oral,presentation of ...clinical,trial of TG101348 in myeloproliferative ...merican Society of Hematology (ASH) Meeting. , ..., Title: A Phase I Study of TG10... JAK2-Selective Inhibitor, in Patients with, ...
(Date:12/1/2008)... a two-way switch that, if turned off, causes lymp... they lose their identity and become more like blo...c. 1 Scientists at St.... that a certain differentiated cell type is so rea...stant expression of a gene called Prox1 to dissu...
(Date:12/1/2008)...ay, December 9 at 11:00 am ET to Discuss Phase 2 S...ISCO, Calif., Dec. 1 S...biopharmaceutical company focused on the developme...ics, today announced new data from its studies of ...presented during the 50th American Society of Hema...
Breaking Medicine Technology:Micromet Expands Committed Equity Financing Facility to $75 Million 2Micromet Expands Committed Equity Financing Facility to $75 Million 3Micromet Expands Committed Equity Financing Facility to $75 Million 4Micromet Expands Committed Equity Financing Facility to $75 Million 5Micromet Expands Committed Equity Financing Facility to $75 Million 6Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 2Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 3Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 2Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 3Stern + Associates Signs New Clients to Health Care Practice 26591 1Stern + Associates Signs New Clients to Health Care Practice 26591 2Hurricane Devastation Touches the Nations Blood Supply 26589 1Hurricane Devastation Touches the Nations Blood Supply 26589 2AdvaMed 2008 Sponsor Participation Increases by 52 25 26587 1AdvaMed 2008 Sponsor Participation Increases by 52 25 26587 2AdvaMed 2008 Sponsor Participation Increases by 52 25 26587 3AdvaMed 2008 Sponsor Participation Increases by 52 25 26587 4alli 28TM 29 Partners with Breast Cancer Network of Strength 28TM 29 to Support Women Challenged by Breast Cancer Weight Loss or Both 7814 1alli 28TM 29 Partners with Breast Cancer Network of Strength 28TM 29 to Support Women Challenged by Breast Cancer Weight Loss or Both 7814 2alli 28TM 29 Partners with Breast Cancer Network of Strength 28TM 29 to Support Women Challenged by Breast Cancer Weight Loss or Both 7814 3
...GE, Mass.--(BUSINESS WIRE)--Apr 17, 2007 - Alnylam...NAi therapeutics,company, announced today at the A...7 Annual Meeting that it will advance a,systemical...treatment of liver cancer and potentially other so... is an RNAi therapeutic that is,designed to target...
...IEJO, Calif.--(BUSINESS WIRE)--Apr 18, 2007 - Avan...ositive top-line,results from the company,s Phase ...drug Zenvia(TM) (dextromethorphan,hydrobromide/qui...gma-1 agonist, in diabetic neuropathic pain., The ...ly diary,entries for the Pain Rating Scale as defi...
Other Medicine Technology:Alnylam Announces Advancement of a New RNAi Therapeutic Development,Program for the Treatment of Liver Cancer 2Alnylam Announces Advancement of a New RNAi Therapeutic Development,Program for the Treatment of Liver Cancer 3Alnylam Announces Advancement of a New RNAi Therapeutic Development,Program for the Treatment of Liver Cancer 4Alnylam Announces Advancement of a New RNAi Therapeutic Development,Program for the Treatment of Liver Cancer 5Avanir Pharmaceuticals Announces Positive Results of Phase III,Study for Zenvia in Diabetic Neuropathic Pain 2Avanir Pharmaceuticals Announces Positive Results of Phase III,Study for Zenvia in Diabetic Neuropathic Pain 3Avanir Pharmaceuticals Announces Positive Results of Phase III,Study for Zenvia in Diabetic Neuropathic Pain 4Avanir Pharmaceuticals Announces Positive Results of Phase III,Study for Zenvia in Diabetic Neuropathic Pain 5Avanir Pharmaceuticals Announces Positive Results of Phase III,Study for Zenvia in Diabetic Neuropathic Pain 6